Lymphangioleiomyomatosis--presence of receptor tyrosine kinases and the angiogenesis factor VEGF-A as potential therapeutic targets.
Watz
Henrik
H
Engels
Knut
K
Loeschke
Siegfried
S
Amthor
Michael
M
Kirsten
Detlef
D
Magnussen
Helgo
H
D005260:Female; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D018192:Lymphangioleiomyomatosis / Q000378:metabolism*; D020794:Receptor Protein-Tyrosine Kinases / Q000378:metabolism*; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*
C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D020794:Receptor Protein-Tyrosine Kinases